Microcin MccI47 selectively inhibits enteric bacteria and reduces carbapenem-resistant Klebsiella pneumoniae colonization in vivo when administered via an engineered live biotherapeutic

References

• Kadri SS. Key takeaways from the U.S. CDC’s 2019 antibiotic resistance threats report for frontline providers. Crit Care Med. 2020;48(7):939–14. doi:10.1097/CCM.0000000000004371.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-4.
   PubMed Web of Science ®Google Scholar
• Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY. Potential economic burden of carbapenem-resistant enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48.e9–.e16. doi:10.1016/j.cmi.2016.09.003.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/s1473-3099(17)30753-3.
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, Pratt NF, Garlick JS, Watson KM, Pilcher DV, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270.
   PubMed Web of Science ®Google Scholar
• World Health O. Antimicrobial resistance: global report on surveillance. Geneva: World Health Organization; 2014.
   Google Scholar
• Jacoby GA, Strahilevitz J, Hooper DC, Tolmasky M, Alonso JC, Tolmasky M, Alonso JC. Plasmid-mediated quinolone resistance. Microbiology Spectrum. 2014;2(5):2.5.33. doi:10.1128/microbiolspec.PLAS-0006-2013.
   PubMedGoogle Scholar
• Wong MHY, Chan EWC, Evolution CS. Dissemination of OqxAB-Like efflux pumps, an emerging quinolone resistance determinant among members of enterobacteriaceae. Antimicrob Agents Chemother. 2015;59(6):3290–3297. doi:10.1128/AAC.00310-15.
   PubMed Web of Science ®Google Scholar
• Atarashi K, Suda W, Luo C, Kawaguchi T, Motoo I, Narushima S, Kiguchi Y, Yasuma K, Watanabe E, Tanoue T, et al. Ectopic colonization of oral bacteria in the intestine drives T H 1 cell induction and inflammation. Science. 2017;358(6361):359–365. doi:10.1126/science.aan4526.
   PubMed Web of Science ®Google Scholar
• Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, Zhao X, Li N, Li S, Xue G, et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 2019;30(4):675–88.e7. doi:10.1016/j.cmet.2019.08.018.
   PubMed Web of Science ®Google Scholar
• Septimus EJ, Schweizer ML. Decolonization in prevention of health care-associated infections. Clin Microbiol Rev. 2016;29(2):201–222. doi:10.1128/cmr.00049-15.
   PubMed Web of Science ®Google Scholar
• Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. The evolution of the host microbiome as an ecosystem on a leash. Nature. 2017;548(7665):43–51. doi:10.1038/nature23292.
   PubMed Web of Science ®Google Scholar
• Granato ET, Meiller-Legrand TA, Foster KR. The evolution and ecology of bacterial warfare. Current Biol. 2019;29(11):R521–R37. doi:10.1016/j.cub.2019.04.024.
   PubMed Web of Science ®Google Scholar
• Fleming A. On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzæ Br J Exp Pathol. 1929;10:226–236.
   Google Scholar
• Fjell CD, Hiss JA, Hancock REW, Schneider G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov. 2012;11(1):37–51. doi:10.1038/nrd3591.
   Web of Science ®Google Scholar
• Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19(3):491–511. doi:10.1128/cmr.00056-05.
   PubMed Web of Science ®Google Scholar
• Telhig S, Ben Said L, Zirah S, Fliss I, Rebuffat S. Bacteriocins to thwart bacterial resistance in gram negative bacteria. Front Microbiol. 2020;11:(2807). doi:10.3389/fmicb.2020.586433.
   PubMed Web of Science ®Google Scholar
• Sassone-Corsi M, Nuccio SP, Liu H, Hernandez D, Vu CT, Takahashi AA, Edwards RA, Raffatellu M. Microcins mediate competition among enterobacteriaceae in the inflamed gut. Nature. 2016;540(7632):280–283. doi:10.1038/nature20557.
   PubMed Web of Science ®Google Scholar
• Gargiullo L, Del Chierico F, D’Argenio P, Putignani L. Gut microbiota modulation for multidrug-resistant organism decolonization: present and future perspectives. Front Microbiol. 2019;10:1704. doi:10.3389/fmicb.2019.01704.
   PubMed Web of Science ®Google Scholar
• Palmer JD, Mortzfeld BM, Piattelli E, Silby MW, McCormick BA, Microcin BV. H47: a class IIb microcin with potent activity against multidrug resistant enterobacteriaceae. ACS Infect Dis. 2020;6(4):672–679. doi:10.1021/acsinfecdis.9b00302.
   PubMed Web of Science ®Google Scholar
• Palmer JD, Piattelli E, McCormick BA, Silby MW, Brigham CJ, Bucci V. Engineered probiotic for the inhibition of salmonella via tetrathionate-induced production of microcin H47. ACS Infect Dis. 2018;4(1):39–45. doi:10.1021/acsinfecdis.7b00114.
   PubMed Web of Science ®Google Scholar
• Vassiliadis G, Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J. Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother. 2010;54(1):288–297. doi:10.1128/aac.00744-09.
   PubMed Web of Science ®Google Scholar
• Azpiroz MF, Laviña M. Involvement of enterobactin synthesis pathway in production of microcin H47. Antimicrob Agents Chemother. 2004;48(4):1235–1241. doi:10.1128/aac.48.4.1235-1241.2004.
   PubMed Web of Science ®Google Scholar
• Laviña M, Gaggero C, Microcin MF. H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol. 1990;172(11):6585–6588. doi:10.1128/jb.172.11.6585-6588.1990.
   PubMed Web of Science ®Google Scholar
• Orellana C, Lagos R. The activity of microcin E492 from Klebsiella pneumoniae is regulated by a microcin antagonist. FEMS Microbiol Lett. 1996;136(3):297–303. doi:10.1111/j.1574-6968.1996.tb08064.x.
   PubMed Web of Science ®Google Scholar
• Poey ME, Azpiroz MF, Laviña M. Comparative analysis of chromosome-encoded microcins. Antimicrob Agents Chemother. 2006;50(4):1411–1418. doi:10.1128/aac.50.4.1411-1418.2006.
   PubMed Web of Science ®Google Scholar
• Hoerr V, Duggan GE, Zbytnuik L, Poon KK, Große C, Neugebauer U, Methling K, Löffler B, Vogel HJ. Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics. BMC Microbiol. 2016;16:82. doi:10.1186/s12866-016-0696-5.
   PubMed Web of Science ®Google Scholar
• Baquero F, Lanza VF, Baquero M-R, Del Campo R, Bravo-Vázquez DA. Microcins in enterobacteriaceae: peptide antimicrobials in the eco-active intestinal chemosphere. Front Microbiol. 2019;10:(2261). doi:10.3389/fmicb.2019.02261.
   Web of Science ®Google Scholar
• Pradhan S, Weiss AA, Barbour AG. Probiotic properties of Escherichia coli Nissle in human intestinal organoids. mBio. 2020;11(4):e01470–20. doi:10.1128/mBio.01470-20.
   PubMed Web of Science ®Google Scholar
• Sonnenborn U, Schulze J. The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microb Ecol Health Dis. 2009;21(3–4):122–158. doi:10.3109/08910600903444267.
   Google Scholar
• Crook N, Ferreiro A, Gasparrini AJ, Pesesky MW, Gibson MK, Wang B, Sun X, Condiotte Z, Dobrowolski S, Peterson D, et al. Adaptive strategies of the candidate probiotic E. coli Nissle in the mammalian gut. Cell Host Microbe. 2019;25(4):499–512.e8. doi:10.1016/j.chom.2019.02.005.
   PubMed Web of Science ®Google Scholar
• Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat Commun. 2020;11(1):1738. doi:10.1038/s41467-020-15508-1.
   PubMed Web of Science ®Google Scholar
• Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA, et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol. 2018;36(9):857–864. doi:10.1038/nbt.4222.
   PubMed Web of Science ®Google Scholar
• Leventhal DS, Sokolovska A, Li N, Plescia C, Kolodziej SA, Gallant CW, Christmas R, Gao J-R, James MJ, Abin-Fuentes A, et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun. 2020;11(1):2739. doi:10.1038/s41467-020-16602-0.
   PubMed Web of Science ®Google Scholar
• Forkus B, Ritter S, Vlysidis M, Geldart K, Kaznessis YN. Antimicrobial probiotics reduce Salmonella enterica in Turkey gastrointestinal tracts. Sci Rep. 2017;7(1):40695. doi:10.1038/srep40695.
   PubMedGoogle Scholar
• Kan A, Gelfat I, Emani S, Praveschotinunt P, Joshi NS. Plasmid vectors for in vivo selection-free use with the probiotic E. coli Nissle 1917. ACS Synth Biol. 2021;10(1):94–106. doi:10.1021/acssynbio.0c00466.
   PubMed Web of Science ®Google Scholar
• Davis JH, Rubin AJ, Sauer RT. Design, construction and characterization of a set of insulated bacterial promoters. Nucleic Acids Res. 2010;39(3):1131–1141. doi:10.1093/nar/gkq810.
   PubMed Web of Science ®Google Scholar
• Young TM, Bray AS, Nagpal RK, Caudell DL, Yadav H, Zafar MA, Monack D. Animal model to study Klebsiella pneumoniae gastrointestinal colonization and host-to-host transmission. Infect Immun. 2020;88(11):e00071–20. doi:10.1128/IAI.00071-20.
   PubMed Web of Science ®Google Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205–208. doi:10.1038/nature13828.
   PubMed Web of Science ®Google Scholar
• Caballero S, Kim S, Carter RA, Leiner IM, Sušac B, Miller L, Kim GJ, Ling L, Pamer EG. Cooperating commensals restore colonization resistance to vancomycin-resistant enterococcus faecium. Cell Host Microbe. 2017;21(5):592–602.e4. doi:10.1016/j.chom.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Adolfsen KJ, Callihan I, Monahan CE, Greisen P Jr., Spoonamore J, Momin M, Fitch LE, Castillo MJ, Weng L, Renaud L, et al. Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering. Nat Commun. 2021;12(1):6215. doi:10.1038/s41467-021-26524-0.
   PubMed Web of Science ®Google Scholar
• Starr CG, Wimley WC. Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes. Biochim Biophys Acta Biomembr. 2017;1859(12):2319–2326. doi:10.1016/j.bbamem.2017.09.008.
   PubMed Web of Science ®Google Scholar
• Maroni A, Moutaharrik S, Zema L, Gazzaniga A. Enteric coatings for colonic drug delivery: state of the art. Expert Opin Drug Deliv. 2017;14(9):1027–1029. doi:10.1080/17425247.2017.1360864.
   PubMed Web of Science ®Google Scholar
• Ozdemir T, Fedorec AJH, Danino T, Barnes CP. Synthetic Biology and engineered live biotherapeutics: toward increasing system complexity. Cell Syst. 2018;7(1):5–16. doi:10.1016/j.cels.2018.06.008.
   PubMed Web of Science ®Google Scholar
• Petros AJ, O’Connell M, Roberts C, Wade P, van Saene HK. Systemic antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric ICU. Chest. 2001;119(3):862–866. doi:10.1378/chest.119.3.862.
   PubMed Web of Science ®Google Scholar
• Willing BP, Russell SL, Finlay BB. Shifting the balance: antibiotic effects on host–microbiota mutualism. Nat Rev Microbiol. 2011;9(4):233–243. doi:10.1038/nrmicro2536.
   PubMed Web of Science ®Google Scholar
• Feehan A, Bacterial G-DJ. Gut microbiome-modifying therapies to defend against multidrug resistant organisms. Microorganisms. 2020;8:(2). doi:10.3390/microorganisms8020166.
   PubMed Web of Science ®Google Scholar
• Dsouza M, Menon R, Crossette E, Bhattarai SK, Schneider J, Kim YG, Reddy S, Caballero S, Felix C, Cornacchione L, et al. Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers. Cell Host Microbe. 2022;30(4):583–98.e8. doi:10.1016/j.chom.2022.03.016.
   PubMed Web of Science ®Google Scholar
• Raffatellu M. Learning from bacterial competition in the host to develop antimicrobials. Nat Med. 2018;24(8):1097–1103. doi:10.1038/s41591-018-0145-0.
   PubMed Web of Science ®Google Scholar
• Praveschotinunt P, Duraj-Thatte AM, Gelfat I, Bahl F, Chou DB, Joshi NS, Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut. Nat Commun. 2019;10(1):5580. doi:10.1038/s41467-019-13336-6.
   PubMedGoogle Scholar
• Gibson DG, Young L, Chuang R-Y, Venter JC, Hutchison CA, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–345. doi:10.1038/nmeth.1318.
   PubMed Web of Science ®Google Scholar
• Wycuff DR, Matthews KS. Generation of an AraC-araBAD promoter-regulated T7 expression system. Anal Biochem. 2000;277(1):67–73. doi:10.1006/abio.1999.4385.
   PubMed Web of Science ®Google Scholar
• Gaggero C, Moreno F, Laviña M. Genetic analysis of microcin H47 antibiotic system. J Bacteriol. 1993;175(17):5420–5427. doi:10.1128/jb.175.17.5420-5427.1993.
   PubMed Web of Science ®Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc National Acad Sci. 2000;97(12):6640–6645. doi:10.1073/pnas.120163297.
   PubMed Web of Science ®Google Scholar
• Lee C, Kim J, Shin SG, Hwang S. Absolute and relative QPCR quantification of plasmid copy number in Escherichia coli. J Biotechnol. 2006;123(3):273–280. doi:10.1016/j.jbiotec.2005.11.014.
   PubMed Web of Science ®Google Scholar
• Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13):1–26. doi:10.18637/jss.v082.i13.
   Web of Science ®Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi:10.1038/nmeth.3869.
   PubMed Web of Science ®Google Scholar
• Wipperman MF, Bhattarai SK, Vorkas CK, Maringati VS, Taur Y, Mathurin L, McAulay K, Vilbrun SC, Francois D, Bean J, et al. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nat Commun. 2021;12(1):1141. doi:10.1038/s41467-021-21475-y.
   PubMed Web of Science ®Google Scholar
• Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27(7):1009–1010. doi:10.1093/bioinformatics/btr039.
   PubMed Web of Science ®Google Scholar